ALDOSTERONE SYNTHASE INHIBITORS

The present invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof, wherein Cy, R1 and R2 are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various dise...

Full description

Saved in:
Bibliographic Details
Main Authors SURPRENANT, SIMON, COGAN, DEREK, MARSHALL, DANIEL, RICHARD, FREDERICK, KOSEA, S, YU, MAOLIN, MCKIBBEN, BRYAN, P, BURKE, JENNIFER, CERNY, MATTHEW, A, LORD, JOHN, FADER, LEE, ZHANG, YUNLONG
Format Patent
LanguageEnglish
Serbian
Published 31.10.2018
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof, wherein Cy, R1 and R2 are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
Bibliography:Application Number: RS2018P000970